|
|
Article: Antares Pharma Business Development Head Elected to Chair the Association of Needle-Free Injection Manufacturers (ANFIM).
- Article from:
- PR Newswire
- Article date:
- July 22, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Antares Pharma, Inc. (BULLETIN BOARD: ANTR) announced today that Michael Kasprick, the Company's Executive Director for Corporate Business Development has been elected Chair of the Association of Needle-Free Injection Manufacturers (ANFIM) organization, effective July 15, 2004.
ANFIM (http://www.anfim.com/) was formed in 1997 with the mission of promoting and protecting public health through the advancement of needle-free injection technology. The organization provides exposure, education and information to healthcare, pharmaceutical, health insurance and consumer groups regarding the potential value of needle-free delivery systems. The organization also ...